اذا لم تجد ما تبحث عنه يمكنك استخدام كلمات أكثر دقة.
Snake-bites are well-known medical emergencies in many
parts of the world, especially in rural areas. Agricultural
workers and children are the most affected. The incidence
of snake-bite mortality is particularly high in South-East
Asia.
Snake antivenom provides a specific lifesaving
measure. The current annual need for the treatment
of snake-bite envenoming amounts to 10 million vials
of antivenins. Unfortunately, the present worldwide production capacity is
well below these needs. This trend needs to be reversed through concerted
actions by national, regional and world health authorities and manufacturers
and through effective public–private partnership. The prevention of mortality
and morbidity depend upon availability of antivenom in the health facilities in
these settings and their rational use. Mechanisms need to be developed to
ensure access to antivenom by all needy patients. The health system needs
to respond to this challenge and logistics must be put in place to ensure
timely availability of antivenom at the point of use.
WHO/SEARO had developed guidelines on the management of snakebites which were also published as a special issue of the Southeast Asian
Journal of Tropical Medicine and Public Health in 1999. WHO has supported
countries in developing similar guidelines. To keep pace with the advances
in science and on the basis of global experience, the regional guidelines
have now been revised.